Role of Epigenetic Changes in Hematological Malignancies
Overview
Authors
Affiliations
Inactivation of tumor suppressor genes is an important event contributing to the development of neoplasia. In addition to the classic genetic mechanisms of deletion or inactivating point mutations, growth regulatory genes can be functionally inactivated without alterations of the primary sequence by methylation of cytosine residues in the promoter regions of the genes. After introducing epigenetic phenomena in general and the molecular basis of DNA methylation in more detail, this review will present the broad spectrum of alterations in DNA methylation patterns found in hematopoietic malignancies. In addition, the implications for therapy and prognosis will be discussed.
Amatori S, Persico G, Cantatore F, Rusin M, Formica M, Giorgi L Cancer Gene Ther. 2022; 30(5):671-682.
PMID: 36536122 PMC: 10191840. DOI: 10.1038/s41417-022-00576-w.
Dong A, Yang W, Huang H, Zhou X, He Z, Yao R Oncol Rep. 2020; 44(2):543-554.
PMID: 32468066 PMC: 7336454. DOI: 10.3892/or.2020.7627.
The Emerging Role of H3K9me3 as a Potential Therapeutic Target in Acute Myeloid Leukemia.
Monaghan L, Massett M, Bunschoten R, Hoose A, Pirvan P, Liskamp R Front Oncol. 2019; 9:705.
PMID: 31428579 PMC: 6687838. DOI: 10.3389/fonc.2019.00705.
Palomo L, Malinverni R, Cabezon M, Xicoy B, Arnan M, Coll R Epigenetics. 2017; 13(1):8-18.
PMID: 29160764 PMC: 5837079. DOI: 10.1080/15592294.2017.1405199.
Aberrant DNA Methylation Is Associated with a Poor Outcome in Juvenile Myelomonocytic Leukemia.
Sakaguchi H, Muramatsu H, Okuno Y, Makishima H, Xu Y, Furukawa-Hibi Y PLoS One. 2016; 10(12):e0145394.
PMID: 26720758 PMC: 4697810. DOI: 10.1371/journal.pone.0145394.